About BioTech 2021

Make your plans now to attend the Shenzhen International Biotech & Healthcare Industry Summit and Expo (Biotech 2021) in fall in Shenzhen, China.
Leading professionals in the Biotech & Healthcare industry will gather to discuss cutting-edge technology in Shenzhen, China.
China has made expansion of the biotech industry and improvement of the healthcare sector among its top national priorities.

With more than 20% of the world’s population, China is a key market for biotech products and plays a key role in biotech product development and manufacturing.
This potential for sustained growth and global leadership in the biotech and healthcare Industries makes China an ideal location for business expansion.

International biotech industry experts and healthcare professionals – as well as target customers – will gather in Shenzhen China – the ideal place to organize business cooperation. Join us as an Exhibitor this September

Three Reasons You Should Exhibit at the Shenzhen International Biotech & Healthcare Summit and Exposition

1. Connecting with key decision makers is guaranteed. 

The event is organized by the Chinese government which mandates that top hospital and lab executives and personnel are present at the summit and expo. 

China has made expansion of the biotech industry and improvement of the healthcare sector among its top national priorities. The Chinese government sends invitations to hospitals, and all the key decision makers are required to attend.

2. The government of China allots generous budgets for hospitals and labs to buy equipment.

Not only does the government of China encourage fruitful exchange with international biotech companies, but it also allocates significant funds for hospitals and labs to invest in equipment.

3. Shenzhen Biotech Expo is the leading event for professionals in the Biotech & Healthcare industry in China.

The Biotech Expo first took place in 2012. Since then, it has been very successful. In 2020, product displays of 260 companies and 95 innovative programs attracted more than 30,000 investors and professionals and created valuable business opportunities for enterprises and companies in the biotech and healthcare industry areas.